Authors: Quinones, MA Greenberg, BH Kopelen, HA Koilpillai, C Limacher, MC Shindler, DM Shelton, BJ Weiner, DH

Citation: Ma. Quinones et al., Echocardiographic predictors of clinical outcome in patients with Left Ventricular Dysfunction enrolled in the SOLVD Registry and Trials: Significance of left ventricular hypertrophy, J AM COL C, 35(5), 2000, pp. 1237-1244

Authors: Slawsky, MT Colucci, WS Gottlieb, SS Greenberg, BH Haeusslein, E Hare, J Hutchins, S Leier, CV LeJemtel, TH Loh, E Nicklas, J Ogilby, D Singh, BN Smith, W

Citation: Mt. Slawsky et al., Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure, CIRCULATION, 102(18), 2000, pp. 2222-2227

Authors: Ambrose, J Pribnow, DG Giraud, FD Perkins, KD Muldoon, L Greenberg, BH

Citation: J. Ambrose et al., Angiotensin type 1 receptor antagonism with irbesartan inhibits ventricular hypertrophy and improves diastolic function in the remodeling post-myocardial infarction ventricle, J CARDIO PH, 33(3), 1999, pp. 433-439

Authors: Gurantz, D Cowling, RT Villarreal, FJ Greenberg, BH

Citation: D. Gurantz et al., Tumor necrosis factor-alpha upregulates angiotensin II type 1 receptors oncardiac fibroblasts, CIRCUL RES, 85(3), 1999, pp. 272-279

Authors: Greenberg, BH

Citation: Bh. Greenberg, Role of angiotensin receptor blockers in heart failure not yet RESOLVD, CIRCULATION, 100(10), 1999, pp. 1032-1034

Authors: Cohn, JN Goldstein, SO Greenberg, BH Lorell, BH Bourge, RC Jaski, BE Gottlieb, SO McGrew, F DeMets, DL White, BG

Citation: Jn. Cohn et al., A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure, N ENG J MED, 339(25), 1998, pp. 1810-1816